Holen Sie sich die Stockscreener-App
3.68
6.84%
-0.27
Handel nachbörslich:
3.75
0.07
+1.90%
Exagen Inc Aktie (XGN) Neueste Nachrichten
Short Interest in Exagen Inc. (NASDAQ:XGN) Expands By 65.7% - MarketBeat
B. Riley Cuts Price Target on Exagen to $8 From $18, Keeps Buy Rating - marketscreener.com
XGN: B. Riley Securities Lowers Price Target, Maintains Buy Rati - GuruFocus
Exagen's (XGN) "Buy" Rating Reaffirmed at B. Riley - MarketBeat
Is Exagen Inc. impacted by rising rates2025 Volume Leaders & High Accuracy Investment Signals - mfd.ru
What are Exagen Inc.’s recent SEC filings showingWeekly Gains Summary & Weekly Return Optimization Plans - mfd.ru
How The Exagen (XGN) Story Is Shifting With A New Analyst Price Target - Yahoo Finance
Volume Recap: Does Crescent Capital BDC Inc stock reflect fundamentals2025 Earnings Impact & Daily Profit Focused Stock Screening - baoquankhu1.vn
Benign Growth For Exagen Inc. (NASDAQ:XGN) Underpins Stock's 26% Plummet - 富途牛牛
Trend Report: Will Exagen Inc benefit from current market trendsTrade Entry Summary & Daily Chart Pattern Signals - baoquankhu1.vn
Exagen Inc. (NASDAQ:XGN) Sees Large Growth in Short Interest - MarketBeat
Investors Don't See Light At End Of Exagen Inc.'s (NASDAQ:XGN) Tunnel And Push Stock Down 28% - Sahm
Selling Exagen Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Sahm
Tech Rally: Is Exagen Inc. benefiting from innovation trends2025 Trading Volume Trends & Breakout Confirmation Alerts - baoquankhu1.vn
Exagen Inc. (NASDAQ:XGN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
ETF Watch: How Exagen Inc stock benefits from global expansionJuly 2025 Technicals & Community Consensus Stock Picks - Bộ Nội Vụ
Published on: 2026-01-13 10:11:31 - ulpravda.ru
Analysts Are Bullish on These Healthcare Stocks: Exagen (XGN), Medline, Inc. Class A (MDLN) - The Globe and Mail
How Recent Analyst Resets Are Reframing The Exagen (XGN) Investment Story - Yahoo Finance
Exagen Announces Record 2025 Revenue and Strong Cash Position - TipRanks
Canaccord Genuity maintains Buy rating on Exagen stock amid ASP challenges - Investing.com Canada
California-based Exagen preliminary revenue up 19% in FY25 - Medical Buyer
Exagen (XGN) Reports Strong Annual Growth and Strategic Advances - GuruFocus
Exagen Inc. Reports Preliminary Financial Results for Q4 and Full Year 2025, Highlighting Record Revenue Growth - Quiver Quantitative
Exagen Inc. Announces Select Preliminary 2025 Financial Results - Bluefield Daily Telegraph
Autoimmune testing firm Exagen ends 2025 with record sales and more cash - Stock Titan
Why Exagen Inc. stock could rally in 2025Forecast Cut & Real-Time Sentiment Analysis - Улправда
T Inc Class stock compares with tech leaders2025 Top Gainers & Safe Capital Allocation Plans - ulpravda.ru
Aug Macro: What margin trends mean for Exagen Inc. stockMarket Growth Review & Long-Term Safe Return Strategies - ulpravda.ru
Is Exagen Inc. stock positioned well for digital economyMarket Trend Summary & High Accuracy Swing Entry Alerts - ulpravda.ru
What margin trends mean for Exagen Inc. stockEarnings Growth Summary & Weekly Market Pulse Alerts - ulpravda.ru
What makes Exagen Inc. stock attractive to growth funds2025 Market Overview & Stock Portfolio Risk Management - ulpravda.ru
Revenue Check: Can Huron Consulting Group Inc. stock deliver surprise earnings beat2025 Macro Impact & AI Forecast Swing Trade Picks - ulpravda.ru
2026 world cup usa squad group stage veteran players set piece strategy knockout prediction analysis - ulpravda.ru
ulpravda ru > 2026> Will LIMN stock beat EPS estimatesQuarterly Trade Summary & High Conviction Buy Zone Picks - ulpravda.ru
Will Exagen Inc. stock outperform Dow Jones indexJuly 2025 Catalysts & Long-Term Safe Return Strategies - Улправда
Will Exagen Inc. (E08A) stock split increase liquidityEarnings Risk Report & Stepwise Trade Signal Implementation - ulpravda.ru
How ImmunityBio Inc. stock trades before earningsJuly 2025 Sector Moves & Real-Time Market Trend Scan - ulpravda.ru
Can Exagen Inc. (E08A) stock reach $200 price targetWeekly Gains Report & Community Consensus Picks - Улправда
Is MIMI stock a smart buy before Fed meetingWeekly Trade Summary & Low Risk High Reward Ideas - ulpravda.ru
ulpravda ru > 2026> Is BPYPO stock dividend yield sustainableMarket Risk Analysis & Fast Entry High Yield Tips - ulpravda.ru
Will Exagen Inc. (E08A) stock rise with strong economyMarket Risk Analysis & Daily Risk Controlled Trade Plans - ulpravda.ru
What momentum indicators show for Exagen Inc. stock2025 Big Picture & Weekly High Return Stock Opportunities - ulpravda.ru
Will Exagen Inc. stock benefit from AI adoption2025 Volatility Report & Verified Short-Term Plans - Улправда
How Exagen Inc. stock reacts to job market dataTrade Execution Strategies & Free Rapid Portfolio Appreciation - Улправда
Why Exagen Inc stock could rally in 2025Market Risk Analysis & Real-Time Price Movement Reports - Bộ Nội Vụ
Free cash flow per share of Exagen, Inc. – SWB:E08A - TradingView — Track All Markets
Exagen Inc E08A Stock Analysis and ForecastTrendline Breakouts & Compound Your Gains With Quality Stocks - earlytimes.in
XGN Stock Price, Forecast & Analysis | EXAGEN INC (NASDAQ:XGN) - Chartmill
American Bio Medica (OTCMKTS:ABMC) versus Exagen (NASDAQ:XGN) Head-To-Head Comparison - Defense World
Will Exagen Inc. stock see PE expansionFibonacci Extensions & Build Wealth With Strategy - bollywoodhelpline.com
Will Exagen Inc. stock benefit from automationDividend Yield Trends & Technical + Fundamental = Smarter Investing - bollywoodhelpline.com
Aug Closing: How rising interest rates impact CZFS stockWeekly Market Outlook & Free Accurate Trade Setup Notifications - moha.gov.vn
How the Narrative Surrounding Exagen Is Evolving After New Guidance and Price Target Upgrades - Yahoo Finance
Exagen Inc. (NASDAQ:XGN) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
What Wall Street predicts for Exagen Inc. stock price2025 Pullback Review & Fast Entry Momentum Alerts - Улправда
Exagen Inc. (NASDAQ:XGN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
1.19%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):